Serotonin tranporter methylation and response to cognitive behaviour therapy in children with anxiety disorders

Citations Over TimeTop 10% of 2014 papers

Abstract

Anxiety disorders that are the most commonly occurring psychiatric disorders in childhood, are associated with a range of social and educational impairments and often continue into adulthood. Cognitive behaviour therapy (CBT) is an effective treatment option for the majority of cases, although up to 35-45% of children do not achieve remission. Recent research suggests that some genetic variants may be associated with a more beneficial response to psychological therapy. Epigenetic mechanisms such as DNA methylation work at the interface between genetic and environmental influences. Furthermore, epigenetic alterations at the serotonin transporter (SERT) promoter region have been associated with environmental influences such as stressful life experiences. In this study, we measured DNA methylation upstream of SERT in 116 children with an anxiety disorder, before and after receiving CBT. Change during treatment in percentage DNA methylation was significantly different in treatment responders vs nonresponders. This effect was driven by one CpG site in particular, at which responders increased in methylation, whereas nonresponders showed a decrease in DNA methylation. This is the first study to demonstrate differences in SERT methylation change in association with response to a purely psychological therapy. These findings confirm that biological changes occur alongside changes in symptomatology following a psychological therapy such as CBT.

Related Papers

• → Despite the general correlation of the serotonin transporter gene regulatory region polymorphism (5-HTTLPR) and platelet serotonin concentration, lower platelet serotonin concentration in migraine patients is independent of the 5-HTTLPR variants(2003)32 cited
• → Inhibition of serotonin transport by (+)McN5652 is noncompetitive(2006)8 cited
• → Effects of the Interaction of Variants of the Serotonin Transporter and Brain-Derived Neurotrophic Factor on Platelet Serotonin Levels in Stroke Patients(2011)2 cited
• → Ex vivo monitoring of serotonin transport and serotonin level in rat platelets in the course of treatment with antidepressant drugs(1994)2 cited
• → Methylation of CpG sites in BCL2 major breakpoint region and the increase of BCL2/JH translocation with aging(2015)